NASDAQ$RXST

Rxsight Inc · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

RxSight, Inc. reported financial results, showcasing revenue growth driven by increased sales of LDDs and LALs.

RxSight, Inc. reported a 71% increase in revenue for the fourth quarter of 2021, reaching $8.4 million, driven by growth in LDD and LAL sales. The company's gross profit increased to $2.9 million, but it experienced a net loss of $15.7 million due to increased operating expenses.

  • Achieved fourth quarter revenue of $8.4 million, a 71% increase year-over-year.
  • Sold 45 Light Delivery Devices (LDDs), expanding the installed base to 206.
  • Sold 2,959 Light Adjustable Lenses (LALs).
  • Gross profit for the fourth quarter of 2021 was $2.9 million, or 34% of revenue, compared to $1.4 million, or 28% for the fourth quarter of 2020.

Headline financials

Total Revenue

$8.43M

Previous: $4.91M+71.5%
EPS (adj)

-$0.47

Previous: $0.91-151.6%
Capital Expenditures

$365K

Previous: $538K-32.2%
Free Cash Flow

-$9.09M

Previous: -$8.77M-3.7%
Net Income

-$15.7M

Previous: $26.3M-159.8%
Operating Income

-$14.7M

Previous: -$8.3M-76.7%
Gross Profit

$2.87M

Previous: $1.38M+107.9%
Cash & Equivalents

$24.4M

Previous: $14M+74.1%
Total Assets

$193M

Previous: $101M+91.4%
Stock-Based Comp

$2.92M

Previous: $1.24M+135.8%

Revenue & EPS history

Rxsight · Revenue · Quarterly

$8.43M

Q4 2021+71.5%vs Q4 2020
Beat estimate in 6 of 11 quarters(55%)
ActualEstimate

Revenue by segment

Rxsight · $11.4M total across 2 segments · Q2 2022

  • LAL Revenue
    $5.8M
  • LDD Revenue
    $5.6M

Forward guidance

RxSight projects 2022 full year revenue to be between $40.0 million and $44.0 million, full year gross margin of 35% to 36% of revenue and full year operating expenses of $86.0 million to $90.0 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

-1.1%

Avg return

Earnings day

-2.6%

Avg return

5 days after

+2.8%

Avg return

30 days after

45%

9 / 20 earnings

Positive

+15.1%

Q3 2022

Best reaction

-16.1%

Q2 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-6.6%-21.6%-31.1%
Q4 2025-10.1%-13.5%-28.9%
Q3 2025+8.7%+16.3%+46.7%
Q1 2025-11.2%-11.4%+0.9%
Q4 2024-0.8%-7.8%-9.1%
Q3 2024-12.3%-16.9%-21.2%
Q2 2024+14.6%+21.5%+29.0%
Q1 2024+0.8%-3.8%-5.0%
Q4 2023-5.8%-3.2%-10.9%
Q3 2023+1.8%+9.5%+40.8%
Q2 2023-1.5%-6.3%-1.8%
Q1 2023+9.0%+18.3%+34.0%
Q4 2022+9.7%+4.5%+17.9%
Q3 2022+15.1%+14.6%+18.1%
Q2 2022-2.9%-8.3%-13.3%
Q1 2022-4.3%-3.0%+34.9%
Q4 2021+1.4%-3.2%+1.8%
Q3 2021+3.7%-0.8%-4.0%
Q4 2020-16.1%-18.4%-21.1%
Q2 2021-16.1%-18.4%-21.1%
Q1 2021
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro